Back
  1. Home
  3. Detailled Reference
Request a copy
Poster (Scientific congresses and symposiums)
Dose Reduction of the New Generation Biologics (IL-17 and IL-23 Inhibitors) in Psoriasis: a Pragmatic, Multicentre, Randomized, Controlled, Non-inferiority Study, BeNeBio Study, Baseline Characterisctics
Van Riel, CAM; Van Den Reek, JMPA; Soenen, R. et al.
2023 • EADV
Permalink
https://hdl.handle.net/2268/310105
 

Files (1)Send toDetailsStatisticsBibliographySimilar publications

Files

Full Text
Dose Reduction of the New Generation Biologics (IL-17 and IL-23 Inhibitors) in Psoriasis a Pragmatic - Multicentre - Randomized - Controlled - Non-inferiority Study - BeNeBio Study - Baseline Characterisctics -.pdf
Author postprint (997.44 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to


Details


Disciplines :
Dermatology
Author, co-author :
Van Riel, CAM
Van Den Reek, JMPA
Soenen, R.
Schots, L.
Van dER Schoots, LS.
Willaert, F.
Hillary, T.
Van Lümig, PPM.
Ghislain, PD.
Ossenkoppele, PM.
Lanssens, S.
Prens, B.
Temmerman, L.
Van Doorn, MBA.
Van Der Voort, EAM.
De Bruin-Weller, MS.
Horvath, B.
Nikkels, Arjen ;  Centre Hospitalier Universitaire de Liège - CHU > > Service de dermatologie
Dierckxens, L.
Berends, MAM.
Dodemont, SRP.
Bovenschen, HJ.
Lambert, JLW.
De Jong, EMGJ.
More authors (14 more) Less
Language :
English
Title :
Dose Reduction of the New Generation Biologics (IL-17 and IL-23 Inhibitors) in Psoriasis: a Pragmatic, Multicentre, Randomized, Controlled, Non-inferiority Study, BeNeBio Study, Baseline Characterisctics
Publication date :
October 2023
Number of pages :
1
Event name :
EADV
Event place :
Berlin, Germany
Event date :
du 10 octobre 2023 au 13 octobre 2023
By request :
Yes
Available on ORBi :
since 19 December 2023

Statistics

Number of views
29 (0 by ULiège)
Number of downloads
19 (0 by ULiège)
More statistics

Bibliography

Similar publications


Contact ORBi